Feedback
European Shorting
My Portfolios
Browse Gurus
Print
Email
Bookmark
Chemocentryx Inc has a market cap of $444.9 million; its shares were traded at around $11.91 with and P/S ratio of 14.1.
This is the annual revenues and earnings per share of CCXI over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of CCXI.
CEO Recent Trades:
- President and CEO Thomas J. Schall sold 20,400 shares of CCXI stock on 11/16/2012 at the average price of 12.58. Thomas J. Schall owns at least 2,240,767 shares after this. The price of the stock has decreased by 5.33% since.
- President and CEO Thomas J. Schall sold 22,500 shares of CCXI stock on 11/06/2012 at the average price of 12.01. Thomas J. Schall owns at least 2,279,167 shares after this. The price of the stock has decreased by 0.83% since.
- President and CEO Thomas J. Schall sold 15,000 shares of CCXI stock on 10/01/2012 at the average price of 11.53. Thomas J. Schall owns at least 2,301,667 shares after this. The price of the stock has increased by 3.3% since.
CFO Recent Trades:
- SVP, Finance, CFO and Sec. Susan M Kanaya sold 16,029 shares of CCXI stock on 11/06/2012 at the average price of 11.91. The price of the stock has decreased by 0% since.
- SVP, Finance, CFO and Sec. Susan M Kanaya sold 3,971 shares of CCXI stock on 10/01/2012 at the average price of 11.89. The price of the stock has increased by 0.17% since.
This is the insider trade history vs. stock price of CCXI. For the complete insider trading history of CCXI, click here.
Directors and Officers Recent Trades:
- 10% Owner Partners L P/il Bvf bought 40,000 shares of CCXI stock on 11/06/2012 at the average price of 12. Partners L P/il Bvf owns at least 3,750,277 shares after this. The price of the stock has decreased by 0.75% since.
- Chief Bus. Officer & Treasurer Markus J. Cappel sold 3,676 shares of CCXI stock on 11/06/2012 at the average price of 12.1. Markus J. Cappel owns at least 75,000 shares after this. The price of the stock has decreased by 1.57% since.
- SVP of Medical & Clinical Petrus Bekker sold 9,300 shares of CCXI stock on 11/06/2012 at the average price of 12.01. Petrus Bekker owns at least 62,500 shares after this. The price of the stock has decreased by 0.83% since.
- SVP, Drug Discovery & CSO Juan C. Jaen sold 5,833 shares of CCXI stock on 11/06/2012 at the average price of 12.01. Juan C. Jaen owns at least 55,000 shares after this. The price of the stock has decreased by 0.83% since.
- Director Roger C Lucas sold 5,000 shares of CCXI stock on 11/06/2012 at the average price of 11.59. Roger C Lucas owns at least 85,000 shares after this. The price of the stock has increased by 2.76% since.
For the complete insider trading history of CCXI, click here.
Subscribe RSS
RSS